The role of leukemia-derived B7-H1 (PD-L1) in tumor-T-cell interactions in humans

Experimental Hematology

Volumn 34, Issue 7, 2006, Pages 888-894

  Salih, Helmut Rainer ^a   Wintterle, Sabine ^b   Krusch, Matthias ^a   Kroner, Antje ^b   Huang, Yu Hwa ^b   Chen, Lieping ^c   Wiendl, Heinz ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD69 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; LIGAND; PROGRAMMED DEATH 1 LIGAND; UNCLASSIFIED DRUG;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CD8+ T LYMPHOCYTE; CELL CULTURE; CELL INTERACTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LEUKEMIA CELL; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE ACTIVATION; TUMOR CELL; TUMOR IMMUNITY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; BLOTTING, WESTERN; CELL LINE, TUMOR; COCULTURE TECHNIQUES; FEMALE; FLOW CYTOMETRY; HUMANS; LEUKEMIA; MALE; MIDDLE AGED; T-LYMPHOCYTES;

MURINAE;

EID: 33745195264     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2006.03.006     Document Type: Article

References (24)

1. Chen L. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat Rev Immunol 4 (2004) 336-347
2. Carreno B.M., and Collins M. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu Rev Immunol 20 (2002) 29-53
3. Coyle A.J., and Gutierrez-Ramos J.C. The expanding B7 superfamily: increasing complexity in costimulatory signals regulating T cell function. Nat Immunol 2 (2001) 203-209
4. Kobata T., Azuma M., Yagita H., and Okumura K. Role of costimulatory molecules in autoimmunity. Rev Immunogenet 2 (2000) 74-80
5. Liang L., and Sha W.C. The right place at the right time: novel B7 family members regulate effector T cell responses. Curr Opin Immunol 14 (2002) 384-390
6. Sharpe A.H., and Freeman G.J. The B7-CD28 superfamily. Nat Rev Immunol 2 (2002) 116-126
7. Dong H., Zhu G., Tamada K., and Chen L. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med 5 (1999) 1365-1369
8. + T cells and is overcome by IL-2. Eur J Immunol 32 (2002) 634-643
9. Freeman G.J., Long A.J., Iwai Y., et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 192 (2000) 1027-1034
10. Eppihimer M.J., Gunn J., Freeman G.J., et al. Expression and regulation of the PD-L1 immunoinhibitory molecule on microvascular endothelial cells. Microcirculation 9 (2002) 133-145
11. Mazanet M.M., and Hughes C.C. B7-H1 is expressed by human endothelial cells and suppresses T cell cytokine synthesis. J Immunol 169 (2002) 3581-3588
12. Petroff M.G., Chen L., Phillips T.A., and Hunt J.S. B7 family molecules: novel immunomodulators at the maternal-fetal interface. Placenta 23 suppl A (2002) 95-101
13. Wiendl H., Mitsdoerffer M., Schneider D., et al. Human muscle cells express a B7-related molecule, B7-H1, with strong negative immune regulatory potential: a novel mechanism of counterbalancing the immune attack in idiopathic inflammatory myopathies. FASEB J 17 (2003) 1892-1894
14. Dong H., Strome S.E., Salomao D.R., et al. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med 8 (2002) 793-800
15. Wang S., Bajorath J., Flies D.B., Dong H., Honjo T., and Chen L. Molecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interaction. J Exp Med 197 (2003) 1083-1091
16. Nishimura H., Nose M., Hiai H., Minato N., and Honjo T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 11 (1999) 141-151
17. Nishimura H., Okazaki T., Tanaka Y., et al. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 291 (2001) 319-322
18. Saudemont A., and Quesnel B. In a model of tumor dormancy, long-term persistent leukemic cells have increased B7-H1 and B7.1 expression and resist CTL-mediated lysis. Blood 104 (2004) 2124-2133
19. Saudemont A., Jouy N., Hetuin D., and Quesnel B. NK cells that are activated by CXCL10 can kill dormant tumor cells that resist CTL-mediated lysis and can express B7-H1 that stimulates T cells. Blood 105 (2005) 2428-2435
20. Chen L. B7-H1 connection of innate and adaptive immunity against tumor dormancy. Blood 105 (2005) 2242-2243
21. Wintterle S., Schreiner B., Mitsdoerffer M., et al. Expression of the B7-related molecule B7-H1 by glioma cells: a potential mechanism of immune paralysis. Cancer Res 63 (2003) 7462-7467
22. Magnus T., Schreiner B., Korn T., et al. Microglial expression of the B7 family member B7 homolog 1 confers strong immune inhibition: implications for immune responses and autoimmunity in the CNS. J Neurosci 25 (2005) 2537-2546
23. Schreiner B., Mitsdoerffer M., Kieseier B.C., et al. Interferon-β enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis. J Neuroimmunol 155 (2004) 172-182
24. Kroner A., Mehling M., Hemmer B., et al. PD-1 polymorphism is associated with disease progression in multiple sclerosis. Ann Neurol 58 (2005) 50-57